162 related articles for article (PubMed ID: 9484754)
21. Role of protocol biopsy in early graft dysfunction in renal transplant recipient.
Islam SF; Hadiuzzaman KM; Islam MN; Khanam A; Faroque MO; Ahmed AH
Mymensingh Med J; 2014 Apr; 23(2):286-9. PubMed ID: 24858156
[TBL] [Abstract][Full Text] [Related]
22. Correlation between the Banff 97 classification of renal allograft biopsies and clinical outcome.
Tanaka T; Kyo M; Kokado Y; Takahara S; Hatori M; Suzuki K; Hasumi M; Toki K; Ichimaru N; Yazawa K; Hanafusa T; Namba Y; Oka K; Moriyama T; Imai E; Okuyama A; Yamanaka H
Transpl Int; 2004 Feb; 17(2):59-64. PubMed ID: 14551678
[TBL] [Abstract][Full Text] [Related]
23. Acute renal allograft rejection with severe tubulitis (Banff 1997 grade IB).
Minervini MI; Torbenson M; Scantlebury V; Vivas C; Jordan M; Shapiro R; Randhawa PS
Am J Surg Pathol; 2000 Apr; 24(4):553-8. PubMed ID: 10757402
[TBL] [Abstract][Full Text] [Related]
24. Correlation between Banff classification, acute renal rejection scores, and reversal of rejection.
Gaber LW; Moore LW; Alloway RR; Flax S; Gaber AO
Transplant Proc; 1995 Feb; 27(1):1019. PubMed ID: 7878784
[No Abstract] [Full Text] [Related]
25. Prognostic value of the Banff classification.
Waiser J; Schreiber M; Budde K; Böhler T; Kraus W; Hauser I; Riess R; Neumayer HH
Transpl Int; 2000; 13 Suppl 1():S106-11. PubMed ID: 11111974
[TBL] [Abstract][Full Text] [Related]
26. Antibody-mediated rejection in the Banff classifications of 2007 and 2017: A comparison of renal graft loss prediction capability.
Solar-Cafaggi D; Marino L; Uribe-Uribe N; Morales-Buenrostro LE
Transpl Immunol; 2018 Dec; 51():40-44. PubMed ID: 30170180
[TBL] [Abstract][Full Text] [Related]
27. Effect of histological damage on long-term kidney transplant outcome.
Nankivell BJ; Fenton-Lee CA; Kuypers DR; Cheung E; Allen RD; O'Connell PJ; Chapman JR
Transplantation; 2001 Feb; 71(4):515-23. PubMed ID: 11258430
[TBL] [Abstract][Full Text] [Related]
28. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Gaber AO; First MR; Tesi RJ; Gaston RS; Mendez R; Mulloy LL; Light JA; Gaber LW; Squiers E; Taylor RJ; Neylan JF; Steiner RW; Knechtle S; Norman DJ; Shihab F; Basadonna G; Brennan DC; Hodge EE; Kahan BD; Kahan L; Steinberg S; Woodle ES; Chan L; Ham JM; Schroeder TJ
Transplantation; 1998 Jul; 66(1):29-37. PubMed ID: 9679818
[TBL] [Abstract][Full Text] [Related]
29. A multicenter report on the utilization of Banff grading in acute renal rejection. The 1995 Efficacy Endpoints Conference.
Gaber LW; Moore LW; Gaber AO; First MR; Guttmann RD; Pouletty P; Schroeder TJ; Soulillou JP
Transplant Proc; 1997; 29(1-2):184-5. PubMed ID: 9122954
[No Abstract] [Full Text] [Related]
30. Correlation between Banff classification acute rejection scores and reversal of rejection.
Park KK; Kim HC; Kwon JK; Park SB; Cho WH
Transplant Proc; 1998 Nov; 30(7):3067-8. PubMed ID: 9838351
[No Abstract] [Full Text] [Related]
31. Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
Woodle ES; Xu D; Zivin RA; Auger J; Charette J; O'Laughlin R; Peace D; Jollife LK; Haverty T; Bluestone JA; Thistlethwaite JR
Transplantation; 1999 Sep; 68(5):608-16. PubMed ID: 10507477
[TBL] [Abstract][Full Text] [Related]
32. One-year results of basiliximab induction and tacrolimus associated with sequential steroid and MMF treatment in pediatric kidney transplant recipient.
Montini G; Murer L; Ghio L; Pietrobon B; Ginevri F; Ferraresso M; Cardillo M; Scalamogna M; Perfumo F; Edefonti A; Zanon GF; Zacchello G
Transpl Int; 2005 Jan; 18(1):36-42. PubMed ID: 15612981
[TBL] [Abstract][Full Text] [Related]
33. Surveillance biopsies are superior to functional studies for the diagnosis of acute and chronic renal allograft pathology in children.
Birk PE; Stannard KM; Konrad HB; Blydt-Hansen TD; Ogborn MR; Cheang MS; Gartner JG; Gibson IW
Pediatr Transplant; 2004 Feb; 8(1):29-38. PubMed ID: 15009838
[TBL] [Abstract][Full Text] [Related]
34. Correlation of histology to clinical rejection reversal: a thymoglobulin multicenter trial report.
Gaber LW; Moore LW; Gaber AO; Tesi RJ; Meyer J; Schroeder TJ
Kidney Int; 1999 Jun; 55(6):2415-22. PubMed ID: 10354290
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of renal allograft biopsies with "borderline changes," as defined in the Banff Schema.
Saad R; Gritsch HA; Shapiro R; Jordan M; Vivas C; Scantlebury V; Demetris AJ; Randhawa PS
Transplantation; 1997 Oct; 64(7):992-5. PubMed ID: 9381547
[TBL] [Abstract][Full Text] [Related]
36. Role of renal allograft biopsy in multicenter clinical trials in transplantation.
Gaber LW
Am J Kidney Dis; 1998 Jun; 31(6 Suppl 1):S19-25. PubMed ID: 9631860
[TBL] [Abstract][Full Text] [Related]
37. Acute cellular rejection treatment outcomes stratified by Banff grade in pediatric kidney transplant.
Chen J; Liverman R; Garro R; Jernigan S; Travers C; Winterberg PD
Pediatr Transplant; 2019 Mar; 23(2):e13334. PubMed ID: 30537179
[TBL] [Abstract][Full Text] [Related]
38. Correlation between Banff classification and reversal of acute renal rejection.
Kokado Y; Kyo M; Takahara S; Ichimaru N; Wang JD; Toki K; Miki T; Okuyama A
Transplant Proc; 1998 Nov; 30(7):3064-6. PubMed ID: 9838350
[No Abstract] [Full Text] [Related]
39. The Banff 97 working classification of renal allograft pathology.
Racusen LC; Solez K; Colvin RB; Bonsib SM; Castro MC; Cavallo T; Croker BP; Demetris AJ; Drachenberg CB; Fogo AB; Furness P; Gaber LW; Gibson IW; Glotz D; Goldberg JC; Grande J; Halloran PF; Hansen HE; Hartley B; Hayry PJ; Hill CM; Hoffman EO; Hunsicker LG; Lindblad AS; Yamaguchi Y
Kidney Int; 1999 Feb; 55(2):713-23. PubMed ID: 9987096
[TBL] [Abstract][Full Text] [Related]
40. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology.
Solez K; Axelsen RA; Benediktsson H; Burdick JF; Cohen AH; Colvin RB; Croker BP; Droz D; Dunnill MS; Halloran PF
Kidney Int; 1993 Aug; 44(2):411-22. PubMed ID: 8377384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
